ACT Genomics raises $12.5M series B

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies, Hua Nan Venture Capital, President International Development and UMC Capital also participated. ...